Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ten63 Therapeutics

Request full access

Proprietary drug discovery engine BEYOND, combining physics and AI in hyper-efficient search algorithms, to design potent chemistry against hard targets and exceed conventional therapeutic research…

Durham, United StatesFounded 2018Biotech & Life Sciences

About Ten63 Therapeutics

Ten63 operates in the biotechnology sector, focusing on drug discovery through its proprietary AI-driven platform, BEYOND. The company targets previously undruggable chemical spaces, aiming to develop new therapeutics. Ten63 serves pharmaceutical companies and research institutions, providing them with innovative solutions to complex medical challenges. The business model revolves around leveraging advanced AI and physical models to identify potential drug candidates, which are then validated experimentally. Revenue is generated through partnerships, licensing agreements, and milestone payments from successful drug discoveries. The market for Ten63's services includes global pharmaceutical companies and biotech firms seeking cutting-edge drug discovery technologies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
34
Open positions
None listed
Dealroom signal
86.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Core AI, Spinout, Biotech and Pharma, AI Applications, DT and LS, science-based
Technology
Artificial Intelligence
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Feb 2026 $0 — Bill & Melinda Gates Foundation · Chugai Venture Fund ↗
SERIES A✓Equity / VC May 2023 $16M $64M Morpheus Ventures · Alexandria Venture Investments · Draper Associates · Hatteras Venture Partners ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Ten63 Therapeutics website traffic

Latest recorded traffic for Ten63 Therapeutics is 1.4K monthly website visits, down 65% over the last three months. Ten63 Therapeutics's team grew 25.9% over the past year.

Latest monthly visits1.4K 3-month web change-65% 1-year team growth+25.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Ten63 Therapeutics in the Durham ecosystem

Live from Dealroom

The Ten63 Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A7 investors entered at this stage

  • Morpheus Ventures
  • Alexandria Venture Investments
  • Draper Associates
  • Hatteras Venture Partners
  • Sigma Group
  • Bill & Melinda Gates Foundation
  • Chugai Venture Fund

Other known investors3 additional known investors

  • Duke University
  • Indie Bio
  • Duke Capital Partners
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States92.9%
🇬🇧 United Kingdom3.6%
🇮🇳 India3.6%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ten63 Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ten63 Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.